The Optimal "Time in Range" and "Time below Range" are Difficult to Coordinate in Patients with Type 1 Diabetes

被引:4
|
作者
Sekiguchi, Sho [1 ]
Yamada, Eijiro [1 ]
Nakajima, Yasuyo [1 ]
Matsumoto, Shunichi [1 ]
Yoshino, Satoshi [1 ]
Horiguchi, Kazuhiko [1 ]
Ishida, Emi [1 ]
Uehara, Ryota [1 ]
Okada, Shuichi [1 ]
Yamada, Masanobu [1 ]
机构
[1] Gunma Univ, Dept Med & Mol Sci, Grad Sch Med, 3-39-15 Showa Machi, Maebashi, Gunma 3718511, Japan
来源
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE | 2021年 / 255卷 / 03期
关键词
continuous glucose monitoring; diabetes mellitus; time above range; time below range; time in range;
D O I
10.1620/tjem.255.221
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Achieving the optimal glucose level time in range (TIR), as recently proposed by the "International Consensus on Time in Range," is challenging. We retrospectively analyzed data from 192 patients, including 58 with type 1 diabetes, using the FreeStyle Libre Pro system. This device was used by physicians for continuous glucose monitoring (CGM) and for making therapeutic decisions based on unbiased data, as the patients were blinded to their blood glucose levels during monitoring. The desired 70% TIR among patients with type 2 diabetes corresponded to an HbA1c of 7.7%. Importantly, however, a 70% TIR for patients with type 1 diabetes corresponded to an HbA1c of 6.9%, which diverged markedly from the HbA1c of 7.9% that corresponded to the desired 4% time below range (TBR). Moreover, these dissociations were observed more in patients with type 1 diabetes with a higher % coefficient of variation (> 36%). Hence, while the TIR is strongly correlated with HbA1c, it is difficult to coordinate with the TBR in Japanese patients with type 1 diabetes. As these metrics (which are critical indicators in clinical practice) are rapidly gaining popularity globally, including in Japan, our data strongly support the cautious use of new CGM metrics such as TIR and TBR/time above range, and emphasize the importance of individualized treatment in achieving the optimal TIR and TBR, especially in patients with type 1 diabetes.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [21] Beware the pitfalls of time below range
    Thabit, Hood
    Schofield, Jonathan
    Leelarathna, Lalantha
    DIABETIC MEDICINE, 2023, 40 (11)
  • [22] The influence of time in range on daily mood in adults with type 1 diabetes
    Polonsky, W. H.
    Fortmann, A. L.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (12)
  • [23] Type 1 Diabetes: Time in Target Range Marker of chronic Complications
    Kessing, Richard
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (06) : 403 - 403
  • [24] CHARACTERISTICS OF PEOPLE WITH DIABETES THAT SPEND 15% OR MORE TIME BELOW RANGE
    Isaacs, D.
    Hopcroft, A.
    Chetty, A.
    Holleman, C.
    Blanchette, J.
    Bellini, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A148 - A148
  • [25] IS THE COMBINED TARGET TIME IN RANGE/TIME BELOW RANGE ACHIEVABLE? EVALUATION OF GLYCEMIC PARAMETERS IN TYPE I DIABETES USERS OF FLASH CONTINUOUS GLUCOSE MONITORING SYSTEM
    Rovira, G.
    Avila, T.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A180 - A180
  • [26] COMPARATIVE EVALUATION OF TIME IN RANGE(TIR) AND TIME BELOW RANGE(TBR) IN PERSONS WITH TYPE 1 DIABETES WHO ARE ON BASAL BOLUS INSULIN-ANALOGUES VERSES REGULAR INSULIN.
    Saboo, B.
    Vyas, T.
    Chennamsetti, K.
    Saiyed, M.
    Patel, R.
    Gupta, A.
    Kesavadev, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A17 - A17
  • [27] PERCENTAGE OF TIME IN RANGE THAT DEFINES GOOD GLYCEMIC CONTROL IN PATIENTS WITH TYPE 1 DIABETES.
    Gomez Medina, A. M.
    Henao, D.
    Rebolledo, M.
    Munoz, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A8 - A8
  • [28] Time in Glucose Target Range Indicates the Risk of DPN in Chinese Type 1 Diabetes Patients
    Shen, Wenqi
    Liu, Fang
    DIABETES, 2020, 69
  • [29] Time in Tight Range for Patients With Type 1 Diabetes: Examining the Potential for Increased Alarm Fatigue
    Scheinker, David
    Maahs, David M.
    DIABETES CARE, 2025, 48 (01) : e1 - e2
  • [30] The Prognostic Value of Time in Range in Type 2 Diabetes
    Selvin, Elizabeth
    DIABETES CARE, 2021, 44 (02) : 319 - 320